Abstract
By comparing the CSF proteome between Alzheimer disease (AD) patients and controls it may be possible to identify proteins that play a role in the disease process and thus to study the pathogenesis of AD. We used mini-gel technology in a two-dimensional electrophoresis procedure, sensitive SYPRO Ruby staining and mass spectrometry for clinical screening of disease-influenced CSF proteins in 15 AD patients and 12 controls. The levels of six proteins and their isoforms, including proapolipoprotein, apolipoprotein E, beta-2 microglobulin, retinol-binding protein, transthyretin, and ubiquitin, were significantly altered in CSF of AD patients. The most prominently altered proteins were the apolipoproteins, especially proapolipoprotein.
Original language | English |
---|---|
Pages (from-to) | 611-5 |
Number of pages | 5 |
Journal | NeuroReport |
Volume | 13 |
Issue number | 5 |
Publication status | Published - 2002 Apr 16 |
Externally published | Yes |
Free keywords
- Aged
- Aged, 80 and over
- Alzheimer Disease
- Confidence Intervals
- Female
- Humans
- Longitudinal Studies
- Male
- Patients
- Protein Isoforms
- Proteins
- Proteome
- Statistics, Nonparametric
- Comparative Study